- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04337047
Distress in Crisis Situations During COVID-19
Distress During the COVID-19 Pandemic in France: a National Assessment of At-risk Populations
There are many scales for screening or assessing the impact of a disease. These scales are generally used to diagnose or assess the severity of a disease and are carried out at the request of a physician by the patient. Conversational agents could make it possible to administer these questionnaires remotely, analyse them and use the results on a large scale, without prior medical intervention.
The main objective of this study is to quantify and qualify the distress of a large population in times of pandemic crisis.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Peritraumatic Distress Inventory is the standard tool designed to assess distress in times of crisis. It consists of 13 questions.
Questions will be submitted to the participants from the Vik chatbot. Responses will be analysed and compared according to the demographics and pathologies encountered.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34000
- Wefight
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Age > 18 years old
- Collection of the subject's non-opposition
- Patient registration on Vik breast, Vik asthma, Vik migraine, Vik depression
Exclusion Criteria:
- Patient unable to formulate non-opposition
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Vik sein
Vik sein users
|
questionnaire assesment
|
Vik asthme
Vik asthme users
|
questionnaire assesment
|
Vik migraine
Vik migraine users
|
questionnaire assesment
|
Vik depression
Vik depression users
|
questionnaire assesment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
quantify and qualify distress over a large population in times of pandemic crisis.
Time Frame: 1 month
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
qualify demographic data vs distress over a large population in times of pandemic crisis.
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WefightDistress20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Psychological
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Baylor UniversityCompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
Institut de Recherche Biomedicale des ArmeesCompletedPsychological Stresses
-
Penn State UniversityStony Brook University; National Institute on Aging (NIA); Oregon State University and other collaboratorsCompleted
-
University of California, San FranciscoNational Institute on Aging (NIA); Penn State University; Harvard UniversityCompletedStress | Depressive Symptoms | Psychological Distress | Psychological Stress | Signs and Symptoms | Psychological | Child MaltreatmentUnited States
-
Military Academy at ETH ZurichSwiss Armed ForcesCompletedPsychological Stress | Psychological AdaptationSwitzerland
-
Nagoya City UniversityAichi Health Promotion FoundationCompleted
Clinical Trials on questionnaire assesment
-
University Hospital, LilleCompleted
-
University Hospital, LilleCompletedOsteoporosis | Sars-CoV2France
-
Sanko UniversityCompletedCerebral Palsy | Caregiver BurnoutTurkey
-
University Hospital, LilleCompletedChronic Pain | Sars-CoV2France
-
Sanko UniversityCompletedCerebral Palsy | Muscular Dystrophy | Down Syndrome | Parents | Spina BifidaTurkey
-
Istanbul UniversityRecruitingCerebral Palsy | Care Giving BurdenTurkey
-
Federico II UniversityCompleted
-
University of Roma La SapienzaUniversity of Milan; Azienda Policlinico Umberto I; Pavia IRCCS Mondino di PaviaRecruitingFibromyalgia | Vulvodynia | Chronic Migraine, HeadacheItaly
-
University Hospital, LilleTerminatedRheumatic Diseases | Rheumatoid Arthritis | Sars-CoV2France
-
University Hospital, LilleCompletedRheumatic Diseases | Rheumatoid Arthritis | Chronic Pain | Sars-CoV2France